Skip to content

Hepatic Excision and Ablation Log

Hepatic Excision and Ablation Log

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06870461
Acronym
HEAL
Enrollment
1000
Registered
2025-03-11
Start date
2025-04-01
Completion date
2040-01-31
Last updated
2025-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Liver Tumor, Malignant Liver Tumor

Brief summary

This study aims to establish a registry for liver surgery and ablation procedures to improve patient care, advance research, and enhance surgical quality. The registry will collect pseudonymized data on patient demographics, disease characteristics, procedural details, and outcomes.

Detailed description

The purpose of this registry is to create a comprehensive list of individuals who have undergone liver surgery or liver ablation, allowing researchers and clinicians to assess their data in future studies if they meet the eligibility criteria. All patients who have received liver surgery or liver ablation procedures at our institution will be included in this registry. Information collected as part of the registry will be used solely to assess potential participants' eligibility for research studies, allowing for the evaluation of long-term outcomes, identification of risk factors, and investigation of therapeutic interventions. This data will help to enhance the understanding of the patient population undergoing liver surgery and improve clinical practices. A patient registry is an organized system that uses observational study methods to collect standardized clinical data and other relevant information. It aims to evaluate specific outcomes for individuals who have undergone liver surgery or ablation, serving scientific, clinical, and policy-related purposes. The registry will support the development of targeted research studies and provide valuable insights into the treatment and management of liver diseases.

Interventions

PROCEDURELiver surgery / ablation

Any type of liversurgery or CT-guidede liver ablation

Sponsors

University Hospital, Antwerp
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Both benign and malignant liver lesions are included

Exclusion criteria

\- Intervention performed solely for liver biopsy, without any subsequent surgical resection or ablation.

Design outcomes

Primary

MeasureTime frameDescription
Establishment of a Liver Surgery and Ablation Registry10 yearsThe primary objective of this study is to create a comprehensive registry of patients who have undergone liver surgery or liver ablation. This registry will serve as a foundation for future epidemiological studies, enabling the assessment of long-term outcomes, the identification of risk factors, and the evaluation of potential therapeutic interventions. Data collected will include demographic information, medical history, surgical details, postoperative outcomes, and survival rates. By compiling this data, we aim to better understand the patient population and improve care for individuals undergoing liver surgery or ablation.

Contacts

Primary ContactBart Hendrikx
hepatobiliaireheelkunde@uza.be+3238214327

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026